The largest community of pharma leaders

Aro Biotherapeutics Appoints Anthony Tolcher, MD, to Scientific Advisory Board

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics announced the appointment of Anthony Tolcher, MD, to its Scientific Advisory Board (SAB). Dr. Tolcher will provide strategic counsel on the development of novel Centyrin therapeutic candidates for oncology indications. “We are excited and pleased to have Dr. Tolcher, a well-known leader in translational oncology clinical research join Aro’s SAB,” said Sue Dillon, PhD, Co-founder and Chief Executive Officer of Aro. “As we progress our Centyrin p


Recent Articles

City of Hope Distinguished Scientist Debbie Thurmond Named New Director of Diabetes & Metabolism Research Institute

DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--Debbie C. Thurmond, Ph.D., has been named the...

Did You Know That One in Eight Women Are at Risk for Breast Cancer?

LEHI, Utah & SAN FRANCISCO--(BUSINESS WIRE)--Breast cancer affects one in eight...

Global Companion Diagnostic Market to Surpass US$ 12,114.6 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)-- #CompanionDiagnostic--According to Coherent Market Insights, the global companion diagnostic...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.